Skip to main content

Peer Review reports

From: EZCancerTarget: an open-access drug repurposing and data-collection tool to enhance target validation and optimize international research efforts against highly progressive cancers

Original Submission
17 Jan 2022 Submitted Original manuscript
2 Feb 2022 Reviewed Reviewer Report - Alejandro Schcolnik-Cabrera
13 Feb 2022 Reviewed Reviewer Report - Khalid Raza
15 Feb 2022 Reviewed Reviewer Report - Milad Allahgholi
16 Feb 2022 Reviewed Reviewer Report - Dusan Ruzic
17 Feb 2022 Reviewed Reviewer Report - Rammohan Shukla
25 Feb 2022 Reviewed Reviewer Report - Yi Liu
14 Jun 2022 Author responded Author comments - David Dora
Resubmission - Version 2
14 Jun 2022 Submitted Manuscript version 2
17 Jun 2022 Reviewed Reviewer Report - Alejandro Schcolnik-Cabrera
24 Jun 2022 Reviewed Reviewer Report - Rammohan Shukla
26 Jun 2022 Reviewed Reviewer Report - Yi Liu
30 Aug 2022 Author responded Author comments - David Dora
Resubmission - Version 3
30 Aug 2022 Submitted Manuscript version 3
2 Sep 2022 Reviewed Reviewer Report - Alejandro Schcolnik-Cabrera
7 Sep 2022 Reviewed Reviewer Report - Yi Liu
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
18 Sep 2022 Editorially accepted
1 Oct 2022 Article published 10.1186/s13040-022-00307-9

You can find further information about peer review here.

Back to article page